Journal of
Neuroscience and Behavioral Health

  • Abbreviation: J. Neurosci. Behav. Health
  • Language: English
  • ISSN: 2141-2286
  • DOI: 10.5897/JNBH
  • Start Year: 2009
  • Published Articles: 66

Full Length Research Paper

Neuroprotective activity of Conyza aegyptiaca hydroethanolic extract against ethanol-induced neurodegeneration in adolescent Wistar rat’s brain

Yendubé T. Kantati
  • Yendubé T. Kantati
  • Laboratory of Physiology/Pharmacology, Research Unit in Physiopathology - Bioactive substances and Safety (PSBI), Faculty of Sciences, University of Lomé, Togo.
  • Google Scholar
Kanfitine Digbandjoa
  • Kanfitine Digbandjoa
  • Laboratory of Physiology/Pharmacology, Research Unit in Physiopathology - Bioactive substances and Safety (PSBI), Faculty of Sciences, University of Lomé, Togo.
  • Google Scholar
Mabozou Kpemissi
  • Mabozou Kpemissi
  • Laboratory of Physiology/Pharmacology, Research Unit in Physiopathology - Bioactive substances and Safety (PSBI), Faculty of Sciences, University of Lomé, Togo.
  • Google Scholar
Aboudoulatif Diallo
  • Aboudoulatif Diallo
  • Laboratory of Toxicology, Faculty of Health Sciences, University of Lomé, Togo.
  • Google Scholar
Simplice D. Karou
  • Simplice D. Karou
  • Unité de Recherche en Immunologie et Immunomodulation (UR2IM)/Laboratoire de Microbiologie et de Contrôle de Qualité des Denrées Alimentaires (LAMICODA)/ESTBA, Université de Lomé, Togo.
  • Google Scholar
Povi Lawson-Evi
  • Povi Lawson-Evi
  • Laboratory of Physiology/Pharmacology, Research Unit in Physiopathology - Bioactive substances and Safety (PSBI), Faculty of Sciences, University of Lomé, Togo.
  • Google Scholar
Kossi Metowogo
  • Kossi Metowogo
  • Laboratory of Physiology/Pharmacology, Research Unit in Physiopathology - Bioactive substances and Safety (PSBI), Faculty of Sciences, University of Lomé, Togo.
  • Google Scholar
Kwashie Eklu-Gadegbeku
  • Kwashie Eklu-Gadegbeku
  • Laboratory of Physiology/Pharmacology, Research Unit in Physiopathology - Bioactive substances and Safety (PSBI), Faculty of Sciences, University of Lomé, Togo.
  • Google Scholar

  •  Received: 14 June 2022
  •  Accepted: 07 July 2022
  •  Published: 31 July 2022


Alcohol consumption is a common well-known source of brain damages. This work aimed to evaluate the neuroprotective effect of Conyza aegyptiaca against ethanol-induced neurodegeneration in a Wistar rat binge drinking model. Animals, pretreated orally once a day during 3 days with the hydroethanolic extract of C. aegyptiaca (HECA 250 and 500 mg/kg), received daily intraperitoneally 7 g/kg of ethanol for 3 more days, concomitantly with HECA. Behavioral studies, brains tissue oxidative stress markers (MDA, GSH) assays, blood cell count and biochemistry analysis were performed. In vitro antioxidant activity using DPPH and FRAP tests and phytochemical tests were also realized. The negative geotaxis test showed that HECA 500 rats took significantly less time (3.24 ± 0.49 s, P<0.05 vs Ethanol control) compared to their congeners of Ethanol control group (6.80 ± 1.267 s, P<0.01 vs Sham). HECA treatment lowered significantly MDA levels (P<0.05 vs Ethanol control) and significantly increased GSH levels (P<0.05 vs Ethanol control). HECA treatment also significantly reduced the platelet count (P<0.001 vs Ethanol control). Ethanol 7 g/kg i.p raised hepatic function markers ALT and AST (respectively +27%, P<0.01 and +58.29%, P<0.01 vs Sham), effects significantly reversed by HECA treatments. DPPH scavenging activity with an IC50 of 368.769 ± 16.467 µg/mL and ferric ion reducing power with an EC50 of 139.65 ± 7.14 µg/mL should be related to the polyphenolic compounds found in HECA, tannins and flavonoids in particular. C. aegyptiaca could therefore potentially protect the brain against situations of neurodegeneration such as those observed in acute ethanol neurotoxicity.

Key words: Conyza aegyptiaca, ethanol, brain, antioxidant, neuroprotection, neurodegeneration.


Degenerative damages to brain represent a major societal challenge because more than 50% of neurodevelopmental disabilities are due to perinatal or subsequent  exposure   to   toxins   or   oxidants  such  as environmental pollutants, tobacco and stress, sources of free radicals harmful to biomolecules, membrane structures, and leading to a multitude of neuro-degenerative pathologies (Wang et al., 2021).

Among these potentially brain-damaging xenobiotics is ethanol. Alcohol is a neuroteratogen and its consumption during pregnancy can cause fetal alcohol syndrome (FAS) (Jones and Smith, 1973; Botia et al., 2011). FAS is characterized by growth deficit, mental retardation, and irreversible learning deficits (Chen and Luo, 2010).

 In adolescence, massive binge drinking episodes are responsible for cognitive deficits (Lees et al., 2019). According to Cohen-Kerem and Koren (2003), the cerebral toxicity of alcohol would pass through oxidative-type mechanisms with a massive production of free radicals, the consequences of which can be summarized in two major pathways: an indirect pathway characterized by the reduction of glutathione peroxidase activity, and a direct pathway with the peroxidation of lipids, nucleic acids and proteins by free radicals.

In these conditions, the use of neuroprotective agents with antioxidant capacities could represent a very interesting therapeutic alternative to protect the brain against alcohol-induced oxidative damages. Plants often rich of antioxidant substances are, therefore, excellent candidates for neuroprotection studies. In Togo, a large part of the population continues to use plants remedies for their primary healthcare (Kpodar et al., 2016), including the management of central nervous system disorders (Kantati et al., 2016). Conyza aegyptiaca is one of these medicinal plants of Togolese flora, whose scientific studies have revealed its antioxidant potential through its antimicrobial (Anani et al., 2000), antihypertensive and cardioprotective (Kpegba et al., 2011), antimalarials and insecticides (Mansour and Mohamed, 2013), and antihyperglycemic’s properties (Akakpo et al., 2016, 2017). However, none of these scientific studies have focused on its neuroactive potential. This study was then initiated in order to evaluate the neuroprotective effect of C. aegyptiaca in a model of cerebral damage induced by ethanol.



The plant material is composed of whole plants of C. aegyptiaca harvested in September 2020 in the locality of Danyi located at 90 km northwest of the capital Lomé. A plant specimen was identified with skill assistance of botanists of Botany and Plant Ecology Laboratory, University of Lomé (Togo). The plants were then washed, dried under air conditioning at 20°C for one week, and then powdered.

Preparation of C. aegyptiaca hydroethanolic extract (HECA)

Four hundred grams of the powder were macerated in a  volume  of 4 L of an ethanol-distilled water mixture (50:50, v/v) for 72 h with intermittent manual stirring. The macerate obtained was filtered and evaporated under vacuum at 45°C using a rotary evaporator. The evaporated extract was lyophilized to obtain a dry extract stored in the refrigerator at 4°C until use.

In-vivo protocols


The animal material consisted of 24 rats of the Wistar strain aged of three (3) weeks and weighing between 70 and 123 g. Animals were raised in the animal house of the Department of Animal Physiology of the University of Lomé, housed in standard polypropylene cages and maintained under standard laboratory conditions (temperature 24-25°C, relative humidity and a 12 h/12 h light-dark cycle). They had free access to food and water. Institutional guidelines and ethical principles of Physiology/Pharmacology laboratory (University of Lomé-Togo, ref: 001/2012/ CB-FDS-UL) were followed.

Experimental design

The protocol used in this test is inspired by studies of Botia et al. (2011), slightly modified. Four groups of five rats each were constituted for this test.

The pretreatment phase lasted three days during which the animals of the first 2 groups received distilled water by gavage while the animals of the last two groups received HECA once a day at the respective doses of 250 and 500 mg/kg by gavage as shown in Figure 1. At the end of this pretreatment phase, animals were treated for 3 additional days during which the first group (Sham) received distilled water and NaCl 9‰,  the second group (Ethanol control) received distilled water and 15% ethanol (diluted in NaCl 9‰) twice. Two doses spaced of 2 h (5 g/kg + 2 g/kg) by intraperitoneal injection to reach a final dose of 7 g/kg. The animals of the last two groups continued to receive simultaneously HECA 250 and 500 mg/kg, respectively once a day and ethanol 7 g/kg i.p, in two successive doses as indicated.

Behavioral studies

Negative geotaxis test: 16 h after the end of the treatments, animals were subjected to behavioral tests. Negative geotaxis test was used to measure the ability of rats to orient and move directionally against gravity. Rats are placed head down on a surface inclined at 20°, as previously described by Botia et al. (2011). This situation of discomfort forces them to get back upside down. The time taken by the animals to complete a 90° rotation is reported. The maximum time allowed for rotation was 180 s. Tests were repeated three times.

Righting reflex test: According to the method of Botia et al. (2011), the surface righting reflex test was used to evaluate muscular development and vestibular functions. For this test, rats were placed on a flat surface in a supine position, maintained for 1 s and released. The time required to regain all 4 paws in contact with the testing plane surface was measured with a stopwatch. The tests were carried out three times.

Blood collection and analysis

At the end of the aforementioned tests, animals were anesthetized with diethyl ether by the open mask method, and the blood was collected by the retro-orbital sinus. Blood samples were taken in EDTA tubes for the blood count and in hemolysis tubes for the assay of biochemical parameters. Samples were centrifuged at 3,000 rpm for 10 min and supernatants collected were used for the determination of Alanine Aminotransferase (ALT), Aspartate Aminotransferase (AST), and Alkaline Phosphatase (ALP) using an autoanalyzer (Prietest Touch Plus, Robonik India PVT LTD) and specific spectrophotometric diagnostic kits (PharmaLab, India).

Preparation of brain homogenate

After collecting the animals' blood, they were anesthetized with ether before being decapitated. Brains were quickly removed, rinsed in an ice-cold normal saline solution. 150 mg of brain tissues were then ground in 1 mL of 20 mM Tris-HCl solution, pH=7.4. The homogenates were centrifuged at 3,000 rpm for 10 min. MDA and GSH were assayed on the supernatant (Patsoukis et al., 2005).

Malondialdehyde (MDA) intracerebral level assay

The MDA rate was assessed using the method of Patlolla et al. (2009). A solution of 1-methyl-2-phenylindole (10 nM) was activated by mixing it with FeCl3 (32 µM) in the respective proportions of 75 and 25% (45 mL of 1-methyl-2-phenylindole in acetonitrile + 15 mL of FeCl3). The reaction medium contains 1.3 mL of the solution of 1-methyl-2-phenylindole activated, 500 μl of  standard  MDA  or  brain homogenate and 300 μl of HCl (37%). Reaction tubes were then incubated at 45°C for 60 min and centrifuged at 4,000 rpm for 10 min using an electric centrifuge. The blank is composed of 1.3 mL of activated 1-methyl-2-phenylindole, 500 µl of tris-HCl, pH 7.4 and 300 µl of HCl (37%).

A standard curve was realized using MDA solution at concentration points: 0.625, 1.25, 2.5, 5 and 10 nM. Absorbances were read at 586 nm using a UV-VIS spectrophotometer (Genesys 20, Thermo Scientific).

Intracerebral reduced glutathione (GSH) assay

For this assay, the method of Sedlak and Lindsay (1968) was used. Briefly, to 50 µL of the homogenate or standard GSH were added 150 µL of a Tris HCl solution (0.2 M, pH = 8.2), 10 µl of 5,5-dithiobis-2-nitrobenzoic acid (DNTB 0.01 M), and 790 µl of methanol. Reaction tubes were homogenized and then incubated for 30 min at room temperature.

The standard GSH concentrations used were 800, 600, 400, 200, 100, and 50 µg/mL. After this incubation time, tubes were centrifuged at 3,000 rpm before reading the absorbances at 412 nm using a UV-VIS spectrophotometer (Genesys 20, Thermo Scientific).

In vitro tests

DPPH of antioxidant activity assay

2,2-Diphenyl-1-picryl-hydrazyl (DPPH) test was realized according to  the  method of Sen and Dastidar (2010). To 1.5 mL of the DPPH solution (100 µmol/l), 0.25 mL of methanol (white) or 0.25 mL of methanolic solution of HECA was added into tubes. 10 min after incubation at room temperature, absorbances were red at 517 nm. Ascorbic acid at different concentrations (12.5, 25, 37.5, 50 and 100 µg/mL) served as reference antioxidant. The percentage inhibition of the DPPH radical was calculated using the equation:

% inhibition = ((A0 - Ae) × 100) / Ac.

where A0 represents the absorbance of DPPH alone and Ae represents the absorbance in the presence of the extract or ascorbic acid. The tests were repeated three times.

Ferric ion reduction test (FRAP)

The ability to reduce ferric ions was measured using the method described by Nishaa et al. (2012) slightly modified. The FRAP reagent was generated by mixing 300 mM sodium acetate buffer (pH 3.6), 10.0 mM TPTZ (tripyridyl triazine) solution, and 20.0 mM FeCl3.6H2O solution in a 10:1:1 volume ratio. HECA at different concentrations (50, 100, 250, 500 and 1000 μg/ml) were then added to 3 ml of FRAP reagent and the reaction mixture was incubated at 37°C for 30 min. The increase in absorbance at 593 nm was measured. Fresh working solutions of FeSO4 were used for calibration. Antioxidant capacity based on the ability to reduce ferric ions in the sample was calculated from the linear calibration curve and expressed as mmol FeSO4 equivalents (0.1, 0.2, 0.4, 0.6, 0.8 and 1 mM) per gram of the sample. The tests were repeated three times.

Phytochemical screening

The characterization of the major phytochemical groups was carried out by the colorimetric reactions described by Karumi et al. (2004) and Edeoga et al. (2005) using the appropriate reagents.

Research of tannins

HECA (1 mL) in a test tube was treated with 0.5 mL Molisch's reagent followed by three drops of ferric chloride, leading to a green color in a condensed form, thus indicating the presence of tannins.


HECA (100 mg) was added to 5 ml of 10% sulfuric acid. The mixture was homogenized for 5 min and filtered, treated finally with 0.5 ml of the reagents (Bouchardat or Mayer) in different tubes. The appearance of an orange precipitate, a yellowish precipitate, and a brown precipitate, respectively, indicated the presence of alkaloids.


HECA (4 mL) mixed with distilled water in a test tube was vigorously shaken for 2 min. A foam of about 5 cm formed and stable after about 10 min showed the presence of saponins.


HECA spiked with hydrochloric acid (HCl 2.5 mL) was mixed with 1.5 mL of sodium hydroxide (NaOH) in a test tube. The appearance of a yellow color indicated the presence of flavonoids.


A few drops of 5% ferric chloride FeCl3 were added to 5 mL of HECA. The formation of an intense blackish coloration indicated the presence of polyphenols.

Sterols and triterpenes

1 ml of acetic anhydride and 1 ml of chloroform were added to 100 mg of HECA. After shaking, the resulting solution was separated into two test tubes. One part was used as a control. After addition of 1 ml of concentrated sulfuric acid, the formation of a brownish red or purple ring after a few minutes at the contact zone of the two phases indicates the presence of metabolites. The appearance of a gray or purple coloration indicated the presence of triterpenes, while a blue to gray-green coloration showed the presence of sterols.

Quantitative determination of total flavonoids

The determination of total flavonoids was carried out according to the method described by Kosalec et al. (2004) which is based on their ability to chelate metals including aluminium. To 2 mL of the ethanolic solution of HECA (1 mg/mL) or of rutin (1 mg/mL), were added 2 mL of aluminium chloride (20 mg/mL) and 6 mL of sodium acetate (50 mg/mL).

The blank was made in the same way without HECA, replaced by 2 mL of ethanol. After an incubation time of 150 min, absorbances were read at 440 nm. The total flavonoid content of HECA was determined from the linear regression equation of the calibration curve established with rutin (0-100 µg/mL) and expressed in µg of rutin equivalent per milligram of dry extract (µg Eq/mg of extract). Rutin served as a reference compound. The tests were repeated three times.

Quantitative determination of total phenols and tannins

The determination of total phenols is based on the Folin-Ciocalteu method described by Maksimovi? et al. (2005). Total phenols were assayed after fixing the tannins with polyvinylpolypyrrolidone (PVPP) following two steps. Firstly, to tubes containing 10 mg of PVPP diluted in 500 µL of methanol, 500 µL of HECA 1 mg/mL were added. The mixture thus obtained was homogenized and incubated on ice for 30 min. After centrifugation, 200 μL of the supernatant were transferred into dry tubes for the assay with the Folin-Ciocalteu reagent. The blank did not contain HECA, replaced by 500 µL of methanol. Secondly, Folin-Ciocalteu (200 µL) was added to 200 µL of HECA (1 mg/mL) or to 200 µL of the Gallic Acid solutions (200, 150, 100, 50, 25 and 0 µg/mL) or 200 µL of the solution obtained during the previous step (extract + PVPP). The mixtures were incubated at room temperature for 15 min. After incubation, 800 μL of sodium carbonate solution (700 mM) were added to the mixtures. The blank was prepared with 200 µL of Folin-Ciocalteu, 200 µL of methanol and 800 µL of the sodium carbonate solution (700 mM). Absorbances were read at 735 nm. The quantity of total phenol is expressed in mg equivalent of Gallic Acid/g of extract. The total amount of tannin was calculated using the formula:

DOT = DOExt – (DOExt + PVP)

where DOT = DO tannins, DOExt = DO extracted, and DOExt + PVP = DO extracted + PVP.

Statistical analysis

Values are expressed as Mean ± SEM. GraphPad Prism 8.3.0 software (GraphPad Software Inc., La Jolla, CA, USA) was used for statistical analyses. Comparisons were made using ANOVA and results were considered significant when P< 0.05.


Behavioral studies

Negative geotaxis

Sham animals, injected with NaCl 9‰, turned 90° from a head-down position within less than 3 s (Figure 2), whereas ethanol (7 g/kg) treated animals (Ethanol control group) required 6.80 ± 1.267 s (P<0.01 vs Sham) to perform the same task. HECA 500 mg/kg treatment significantly reduced the deleterious effect of alcohol, bringing back this time to 3.24 ± 0.49 s (P<0.05 vs Ethanol control).

Righting reflex

Ethanol administrated intraperitoneally, either alone or in combination with HECA, did not affect the righting reflexes (Figure 3).

Blood biochemistry

Figure 4a and b shows that treatment with ethanol alone (7 g/kg) caused a significant increase in AST (+58.29%, P<0.01  vs   Sham)  and  ALT  levels  (+27%,  P<0.01  vs Sham). Concomitant administration of HECA 500 mg/kg significantly reduced the AST level to values ??close to normal (-54.71%, P<0.001 vs Ethanol control). For ALT, the two doses of HECA (250 and 500 mg/kg) significantly lowered the levels of this marker (-19.73 and -16.96%, respectively) when compared with ethanol control animals.

Blood cells count

The level of blood platelets increased significantly (+34%, P<0.001 vs Sham) in ethanol control animals. This rate experienced significant decreases in HECA treated rats (-5.80%, P<0.05 at the dose of 250 mg/kg, -12.43% P<0.05 at the dose of 500 mg/kg) when compared with ethanol control animals. For the rest of parameters, no significant variations were observed. The results are shown in Table 1.

Brain MDA levels

The basal level of MDA in brains of Shams was 74.37 ± 10.32 nM/g of tissue. In ethanol control animals, alcohol administration significantly increased lipid peroxidation rate (+22%, P<0.05 vs Sham).

This level was significantly lowered (-28%, P<0.05 vs Ethanol control) by HECA 500 mg/kg treatment (Figure 5).

Brain GSH levels

The  basal  level  of  GSH  in  brains  of  Shams was 0.38 ±0.013 nM/g of tissue (Figure 6). A significant reduction was observed in brain samples when animals received ethanol at dose of 7 g/kg (-26.66%, P<0.01 vs Sham). Treatment with HECA restored GSH levels. The best activity was recorded with HECA 500 mg/kg (+13.33 P<0.05 vs Ethanol control).

In vitro antioxidant studies

DDPH free radical scavenging capacity

HECA inhibited 50% of DPPH free radicals (IC50) at dose of 344.985 ± 17.139 µg/mL as presented in Figure 7, although  lower  than  that  of  the  reference  molecule ascorbic acid which IC50 was 23.468 ± 0.091 µg/mL.

Ferric ion reducing power

HECA also clearly reduced ferric ions (Fe3+) with an EC50 of 139.65 ± 7.14 µg/mL. Reference compounds quercetin and ascorbic acid, respectively presented EC50 of 48.52 ± 2.02 and 23.06 ± 0.21 µg/mL shown in Table 2.


Qualitative content

Table  3  summarizes the major chemical groups found in HECA.

Quantitative content

The amount of flavonoids, total polyphenols and tannins found in the extract are shown in Table 4.


The present study aimed to evaluate the neuroprotective effect of HECA in an animal model of ethanol intoxication. Ethanol neurotoxicity is strongly linked to oxidative stress (Diallo et al., 2009) and inflammatory mechanisms. The review of Crews and Nixon (2009) described well preclinical rat experiments using  a  4-day  binge  ethanol treatment known to induce brain damages. Binge drinking is defined as heavy alcohol consumption followed by periods of abstinence during adolescence (Reitz et al., 2021). In this model, the peak of neurodegeneration generally occurs on the 3rd day after the animals have received ethanol (Crews and Nixon, 2009). Neurodegeneration and cognitive deficits following binge treatment mimic the mild degeneration and cognitive deficits found in humans. Therefore, it is in a well-known model of neurodegeneration that HECA neuroprotective properties have been tested in this study. Ethanol heavy consumption, through the promotion of reactive oxygen species (ROS) production, causes damages or degradation  of  essential  complex  molecules in the cells (lipids, proteins, and DNA) and reduces the levels of antioxidants enzymes, glutathione (GSH) in particular (Wu and Cederbaum, 2003). Evaluation of neuroprotection by assessing lipid peroxidation (MDA) and GSH levels in the brain tissues show that HECA clearly protected animal’s CNS from oxidative effects of ethanol. GSH is the most abundant thiol compound in the brain and is considered to be the major regulator of the intracellular redox state by participating in redox reactions.

It chelates free radicals or acts as a substrate for many antioxidant enzymes (Migdal and Serres, 2011). According  to   the   pesent   results,   the   level   of  GSH decreased significantly in ethanol control animals. This decrease could be explained by its participation in the inhibition of oxidative stress, but also by the indirect action of ethanol on glutathione levels as mentioned earlier in this paper (Cohen-Kerem and Koren, 2003). The increase in the intracerebral level of the marker of lipoperoxidation, MDA, indicates an increase in the production of free radicals in ethanol control animals. Excessive exposure to ethanol leads to cerebellar dysfunction with cerebellar ataxia and alterations in postural stability, motor skills and balance (Luo, 2015). Since ethanol-induced neurodegeneration is the cause of behavioral disorders, we investigated the neuroprotective capacity of HECA by performing geotaxis and righting behavioral tests. The geotaxis test performed assesses motor coordination in rats. The rats are placed face down on a 20° slopping surface and due to the vestibular cues of gravity, they turn around to face the slope. The action of neurotoxins causing brain damage would alter this reflex and increase the turning time of animals (Ten et al., 2003; Elnar et al., 2012).

The results indicate a significant increase in the turning time for wthanol controls compared to Sham animals, characteristic of a brain lesion. The significant decrease in repositioning time of HECA 500 mg/kg animals indicates the capacity of this extract to exert neuroprotection, allowing this reflex to be maintained. In fact, HECA 500 mg/kg, in spite of ethanol 7 g/kg presence, lowered significantly the level of MDA and restored GSH levels, offering a good antioxidant protection in the brain. Interestingly, this study found that this protection was not only limited to brain. Ethanol, like many other chemicals, is mainly metabolized in  the  liver, making this organ a target of its peripheral toxicity (Comporti et al., 2010). Dosage of hepatic markers ALT, AST and ALP revealed a possible hepatoprotective effect of HECA, since alterations induced by alcohol have been reversed by the treatment with this plant extract. This also indicates a possible better alcohol elimination process.

These observations, linked to those of anti-lipoperoxidation and glutathione restoration, suggest that the neuroprotection confirmed in behavioral studies should be mediated by a general amelioration of animal’s antioxidant status in the presence of HECA.

Moreover, a significant increase in the level of blood platelets in ethanol treated animals was observed. As Femia et al. (2013) have demonstrated in their studies in healthy patients that there is a correlation between platelet count and extent of platelet aggregation, the increased platelet count should be linked to an elevated risk of rat’s blood platelet aggregation. This phenomenon called,  “platelet  rebound”  is  very  well  known in alcohol studies such as binge drinking models. Many studies carried out both in humans and in animals define it as a mark of alcohol withdrawal (Renaud and Ruf, 1996). Ruf et al. (1995) showed earlier that alcohol deprivation of rats for 18 h was associated with an increase in the platelet response of 124% in those receiving 6% ethanol, of 46% with white wine but a decrease of 59% in those with red wine. This protection afforded by wine has been duplicated later in animals with grape phenolics added to alcohol (Ruf, 2004), confirming that phenolic antioxidants have protective effect on platelets rebound, a deleterious phenomenon characterized by higher responses of platelets to thrombin and ADP-induced aggregation, higher level of lipid peroxides and conjugated dienes in animals receiving alcohol (Ruf et al., 1995). Considering that high amounts of alcohol and its metabolites exert direct inflammatory effects on the brain and liver and induce free-radical production, therefore increasing lipid peroxidation and tissue inflammation (Jayatilleke and Shaw, 1998; Chen et al., 2016), we hypothesized that HECA should also possess anti-inflammatory property.

The hydroethanolic extract of C. aegyptiaca revealed a wide variety of major chemical groups with pharmacological activity.

Tannins and flavonoids in particular are considered as useful antioxidant and anti-inflammatory compounds (Yessoufou et al., 2013; Ferrini et al., 2021; Mali?ski et al., 2021). Regarding the antioxidant capacity evaluated by the DPPH and FRAP tests, HECA exhibited good free radicals scavenging capacities. Through these demonstrated antioxidant capacities, HECA would therefore have protected neuronal cells from death by inhibiting lipid peroxidation and restoring GSH levels in midbrain, and by ameliorating the total antioxidant status of animals as shown by peripheral tissues (blood and liver) function exploration.


The hydroethanolic extract of C. aegyptiaca showed interesting antioxidant activities in vitro and an ability in vivo to protect the brain against ethanol-induced neuronal damage. C. aegyptiaca therefore possesses neuroprotective activity in a model of ethanol neurodegeneration in the wistar rat. The presence of polyphenolic compounds, tannins and flavonoids, probably explains these activities. HECA should be then an excellent source of new pharmaceutical neuroactive agents. Furthermore, other studies are needed to validate these neuroprotective properties and verify its toxicological profile before recommending its use as possible neuroprotective natural remedy.


The authors have not declared any conflict of interests.


Akakpo B, Akpovi CD, Aïkpe J, Kinsou L, Joachim Djimon G, Dansou P (2017). Conyza aegyptiaca (L.) Dryand ex. Aiton effect on blood glucose levels in normal albinos rats through oral glucose tolerance test. International Journal of Current Research in Chemistry and Pharmaceutical Sciences 4(4):19-26. 


Akakpo BH, Akpovi CD, Medehouenou TCM, Assogba FM, Dansou PH, Gbénou JD (2016). Conyza aegyptiaca (L.) Dryand ex. Aiton extracts exhibite antioxidant activity and prevent hepatic glucose liberation in vitro. International Journal of Biosciences 9(6):431 439. 


Anani K, de Souza C, Akpagana K, Tower GHN, Arnason JT, Gbeassor M, Hudson JB (2000). Investigation of Medicinal Plants of Togo for Antiviral and Antimicrobial Activities. Pharmaceutical Biology 38(1):40 45. 


Botia B, Jolivel V, Burel D, Le Joncour V, Roy V, Naassila M, Bénard M, Fournier A, Vaudry H, Vaudry D (2011). Neuroprotective effects of PACAP against ethanol-induced toxicity in the developing rat cerebellum. Neurotoxicity Research 19(3):423-34. 


Chen G, Luo J (2010). Anthocyanins?: Are They Beneficial in Treating Ethanol Neurotoxicity? Neurotoxicity Research 17(1):91 101. 


Chen WW, Zhang X, Huang WJ (2016). Role of neuroinflammation in neurodegenerative diseases (Review). Molecular Medicine Reports 13(4):3391 3396. 


Cohen-Kerem R, Koren G (2003). Antioxidants and fetal protection against ethanol teratogenicity. Neurotoxicology and Teratology 25(1):1 9.


Comporti M, Signorini C, Leoncini S, Gardi C, Ciccoli L, Giardini A, Arezzini B (2010). Ethanol-induced oxidative stress: basic knowledge. Genes and nutrition 5(2):101-109. 


Crews FT, Nixon K (2009). Mechanisms of Neurodegeneration and Regeneration in Alcoholism. Alcohol and Alcoholism 44(2):115 127. 


Diallo A, Eklu-Gadegkeku K, Mobio T, Moukha S, Agbonon A, Aklikokou K, Creppy EE, Gbeassor M (2009). Protective Effect of Moringa oleifera Lam. And Lannea kerstingii Extracts Against Cadmium and Ethanol-induced Lipid Peroxidation. Journal of Pharmacology and Toxicology 4(4):160 166. 


Edeoga HO, Okwu DE, Mbaebie BO (2005). Phytochemical constituents of some Nigerian medicinal plants. African Journal of Biotechnology 4(7):685 688. 


Elnar AA, Diesel B, Desor F, Feidt C, Bouayed J, Kiemer AK, Soulimani R (2012). Neurodevelopmental and behavioral toxicity via lactational exposure to the sum of six indicator non-dioxin-like-polychlorinated biphenyls (∑6 NDL-PCBs) in mice. Toxicology 299(1):44-54. 


Femia EA, Scavone M, Lecchi A, Cattaneo M (2013). Effect of platelet count on platelet aggregation measured with impedance aggregometry (MultiplateTM analyzer) and with light transmission aggregometry. Journal of Thrombosis and Haemostasis 11:2193-2196. 


Ferrini L, Rodríguez JP, Melana Colavita JP, Olea G, Ojeda GA, Ricciardi G, Torres AM, Aguirre MV (2021). Anti-inflammatory activity of Nectandra angustifolia (Laurel Amarillo) ethanolic extract. Journal of Ethnopharmacology 272:113937. 


Jayatilleke A, Shaw S (1998). Stimulation of monocyte interleukin-8 by lipid peroxidation products: a mechanism for alcohol-induced liver injury. Alcohol 16(2):119-23. 


Jones KL, Smith DW (1973). Recognition of the fetal alcohol syndrome in early infancy. Lancet 302(7836):999-1001. 


Kantati YT, Kodjo KM, Dogbeavou KS, Vaudry D, Leprince J, Gbeassor M (2016). Ethnopharmacological survey of plant species used in folk medicine against central nervous system disorders in Togo. Journal of Ethnopharmacology 181:214-220. 


Karumi Y, Onyeyili PA, Ogugbuaja VO (2004). Identification of Active Principles of M. balsamina (Balsam Apple) Leaf Extract. Journal of Medical Sciences 4(3):179 182.


Kosalec I, Bakmaz M, Pepeljnjak S, Vladimir-Knezevi? S (2004). Quantitative analysis of the flavonoids in raw propolis from northern Croatia. Acta Pharmaceutica 54(1):65 72. PMID: 15050046.


Kpegba K, Amouzou E, Agbonon A, Gbeassor M (2011). Effect of conyza aegyptiaca on the frog semi isolated heart. Journal of Applied Pharmaceutical Science 1(7):36 39.


Kpodar MS, Karou SD, Katawa G, Anani K, Gbekley HE, Adjrah Y, Tchacondo T, Batawila K, Simpore J (2016). An ethnobotanical study of plants used to treat liver diseases in the Maritime region of Togo. Journal of Ethnopharmacology 181:263 273. 


Lees B, Mewton L, Stapinski LA, Squeglia LM, Rae CD, Teesson M (2019). Neurobiological and Cognitive Profile of Young Binge Drinkers?: A Systematic Review and Meta-Analysis. Neuropsychology Review 29(3):357 385. 


Luo J (2015). Effects of Ethanol on the Cerebellum?: Advances and Prospects. The Cerebellum 14(4):383 385. 


Maksimovi? Z, Malenci? D, Kovacevi? N (2005). Polyphenol contents and antioxidant activity of Maydis stigma extracts. Bioresource Technology 96(8):873 877. 


Mali?ski MP, Kikowska MA, Soluch A, Kowalczyk M, Stochmal A, Thiem B (2021). Phytochemical Screening, Phenolic Compounds and Antioxidant Activity of Biomass from Lychnis flos-cuculi L. In Vitro Cultures and Intact Plants. Plants 10(2):206. 


Mansour SA, Mohamed RI (2013). Insecticidal Properties and Chemical Composition of Conyza Aegyptiaca (L.) Oil?: Studies on Two Dipterous Insect Pests. The Open Toxinology Journal 5(1):1 7. 


Migdal C, Serres M (2011). Espèces réactives de l'oxygène et stress oxydant. médecine/sciences 27(4):405 412. 


Nishaa S, Vishnupriya M, Sasikumar JM, Hephzibah PC, Gopalakrishnan VK (2012). Antioxidant activity of ethanolic extract of Maranta arundinacea L. tuberous rhizomes. Asian Journal of Pharmaceutical and Clinical Research 5(4):85-88.


Patlolla AK, Barnes C, Yedjou C, Velma VR, Tchounwou PB (2009). Oxidative stress, DNA damage, and antioxidant enzyme activity induced by hexavalent chromium in Sprague-Dawley rats. Environmental Toxicology 24(1):66 73. 


Patsoukis N, Zervoudakis G, Georgiou CD, Angelatou F, Matsokis NA, Panagopoulos NT (2005). Thiol Redox State and Lipid and Protein Oxidation in the Mouse Striatum after Pentylenetetrazol-induced Epileptic Seizure. Epilepsia 46(8):1205 1211.


Reitz NL, Nunes PT, Savage LM (2021) Adolescent Binge-Type Ethanol Exposure in Rats Mirrors Age-Related Cognitive Decline by Suppressing Cholinergic Tone and Hippocampal Neurogenesis. Frontiers in Behavioral Neuroscience 15:772857. 


Renaud SC, Ruf JC (1996). Effects of alcohol on platelet functions. Clinica Chimica Acta 246(1 2):77 89. 


Ruf JC (2004). Alcohol, wine and platelet function. Biological research, 37(2):209-215. 


Ruf JC, Berger JL, Renaud S (1995). Platelet rebound effect of alcohol withdrawal and wine drinking in rats: Relation to tannins and lipid peroxidation. Arteriosclerosis, thrombosis, and vascular biology, 15(1):140-144. 


Sedlak J, Lindsay RH (1968). Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Analytical Biochemistry 25(1):192 205.


Sen M, Dastidar M (2010). Chromium removal using various biosorbent. Iranian Journal of Environmental Health Science and Engineering 7(3):182-190.


Ten VS, Bradley-Moore M, Gingrichj JA, Stark RI, Pinsky DJ (2003). Brain injury and neurofunctional deficit in neonatal mice with hypoxic-ischemic encephalopathy. Behavioural Brain Research 145(1 2):209 219. 


Wang J, Ma T, Ma D, Li H, Hua L, He Q, Deng X (2021). The Impact of Air Pollution on Neurodegenerative Diseases. Therapeutic Drug Monitoring 43(1):69-78. 


Wu D, Cederbaum AI (2003). Alcohol, oxidative stress, and free radical damage. Alcohol Research and Health 27(4):277-284. PMID: 15540798


Yessoufou A, Gbenou J, Grissa O, Hichami A, Simonin AM, Tabka Z, Moudachirou M, Moutairou K, Khan NA (2013). Anti-hyperglycemic effects of three medicinal plants in diabetic pregnancy?: Modulation of T cell proliferation. BMC Complementary and Alternative Medicine 13(1):77.